Method v1

The method.

Claim · evidence tier · disclosure · order of operations · human gate · receipts on file.

01

Claim

The bottle's claim appears as quoted material under critique.

02

Receipts

INCI parse, concentration or pH math where available, citations, consensus, and user signal.

03

Verdict

WORTH IT, SKIP IT, OVERPRICED, DUPE EXISTS, or SEALED when a verdict earned the seal.

04

Action

Evidence picks the winner before any monetized link attaches.

Evidence tiers

T1 formulation

  • INCI list.
  • Concentration clues.
  • pH context where it matters.

T2 evidence

  • Citation-shaped support.
  • Consensus signal.
  • Real-user patterning where useful.

T3 firsthand

  • Use experience disclosed on-card.
  • Reserved for cases where it changes the verdict.

The five public gates

G1

Label Truth

Every claim maps to a label, INCI, or brand-stated fact.

G2

Real Dose

Actives show up at a believable use level, not fairy-dust placement.

G3

Fair Price

The price tracks formula value, not campaign gravity.

G4

No Cheaper Equal

No materially equivalent product does the same job for less.

G5

Clean Evidence

Receipts are real, conflicts disclosed, and claims stay cosmetic-safe.

Human integrity hold

High-risk calls can stop for review before publish. The public gate logic stays the same; the hold decides whether a sensitive verdict ships sealed.

Compare method v1.0

INCI order is a regulatory ordering constraint above 1% only; concentrations at or below the 1% line cannot be inferred from order.

Same actives is formulation math, not a performance promise. Texture, stability, and experience can differ.